ArticleScientific reports2025
Development of a novel extension of Rayleigh distribution with application to COVID-19 data.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A novel extension of the power lindley distribution with statistical properties and application to COVID-19 data.Scientific reports · 2025Article
- On multicomponent stress-strength reliability for progressively censored logistic exponential model.Alexandria engineering journal AEJ · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Effective analysis of medical data is essential for understanding complex healthcare phenomena. Probability distribution models offer a structured approach to uncover patterns in such data, particularly for studying disease progression, survival analysis and many more. In this study, we explore a novel probability distribution model, derived by applying the DUS transformation to the standard Rayleigh distribution. We thoroughly investigate the statistical properties of the proposed model and derive key reliability measures to demonstrate its applicability in reliability analysis. To ensure precise parameter estimation, various estimation methods are evaluated, and their effectiveness is assessed through a detailed simulation study using bias, mean squared error, and mean relative error as performance criteria. The developed model's practical applicability is demonstrated with an analysis of COVID-19 data, comparing its performance with several well-known distributions. The results highlight the flexibility and accuracy of the model, establishing it as a powerful and reliable tool for advanced statistical modelling in healthcare research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.